PTC THERAPEUTICS, INC. — Director's Dealing 2015

Mar 23, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2015-03-20

Reporting Person: Boulding Mark Elliott (Exec. VP and CLO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-20	Common Stock	S	13453	$67.77	Disposed	18782	Direct
2015-03-20	Common Stock	S	7547	$68.72	Disposed	11235	Direct
2015-03-20	Common Stock	S	142	$69.77	Disposed	11093	Direct

Footnotes

F1: The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on August 11, 2014 for the primary purposes of covering tax obligations associated with a restricted stock vesting event and diversification.

F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $67.31 to $68.28 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.31 to $69.26 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.